This comprehensive review provides an in-depth analysis of how nanotechnology has
revolutionized cancer theragnostic, which combines diagnostic and therapeutic methods to …

Nucleic acid therapeutics are promising alternatives to conventional anti-cancer therapy,
such as chemotherapy and radiation therapy. While conventional therapies have limitations …

Aptamers represent a distinct category of short nucleotide sequences or peptide molecules
characterized by their ability to bind to specific targets with high precision. These molecules …

Background Existing liquid biopsy assays for protein biomarkers of cancer are mostly based
on antibodies (Ab) contributing unfavorably to their high cost. Easy to express and modify in …

Combination of immunotherapy and photothermal therapy (PTT) provides a promising
therapeutic performance for tumors. However, it still faces negative feedback from …

Aptamers are molecular recognition elements that have been extensively deployed in a
wide array of applications ranging from diagnostics to therapeutics. Due to their unique …

The epidermal growth factor receptor (EGFR) is one of the key oncomarkers in glioblastoma
(GB) biomedical research. High levels of EGFR expression and mutations have been found …

Oncolytic virotherapy is a promising approach for cancer treatment. However, when
introduced into the body, the virus provokes the production of virus-neutralizing antibodies …

Abstract Acute Lymphoblastic Leukemia (ALL) is a heterogeneous blood cancer
characterized by the uncontrolled growth of immature lymphoid cells due to dysregulated …

Background/Objectives: Targeted delivery of chemotherapeutic agents is a well-established
approach to cancer therapy. Antibody–drug conjugates (ADCs) typically carry toxic payloads …